| David P Dillon, MD | |
|
15290 Pennock Ln, Apple Valley, MN 55124-7163 | |
| (952) 853-8800 | |
| (952) 431-6966 |
| Full Name | David P Dillon |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 15290 Pennock Ln, Apple Valley, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063527570 | NPI | - | NPPES |
| 34007500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 42535 (Wisconsin) | Secondary |
| 207Q00000X | Family Medicine | 35370 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.
A University of Southampton scientist has just been awarded more than £58,000 by Alzheimer's Research UK to study chemical signals in the brain in Alzheimer's disease. The research will study the chemical signals that control learning and memory in an attempt to understand more about Alzheimer's and search for new treatments.
Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."
The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.
Between 17-21 October 2009, the 39th annual conference of the Society of Neuroscience drew some 30,500 people to the great city of Chicago, which was more balmy than windy for the occasion. Your Alzforum reporters have been busy roaming the halls, buttonholing scientists for their comments on the presentations, and putting together reports on the most significant advances.
› Verified 4 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.
A University of Southampton scientist has just been awarded more than £58,000 by Alzheimer's Research UK to study chemical signals in the brain in Alzheimer's disease. The research will study the chemical signals that control learning and memory in an attempt to understand more about Alzheimer's and search for new treatments.
Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."
The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.
Between 17-21 October 2009, the 39th annual conference of the Society of Neuroscience drew some 30,500 people to the great city of Chicago, which was more balmy than windy for the occasion. Your Alzforum reporters have been busy roaming the halls, buttonholing scientists for their comments on the presentations, and putting together reports on the most significant advances.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David P Dillon, MD 8170 33rd Ave S # Ms 21110q, Minneapolis, MN 55425-4516 Ph: () - | David P Dillon, MD 15290 Pennock Ln, Apple Valley, MN 55124-7163 Ph: (952) 853-8800 |
News Archive
Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.
A University of Southampton scientist has just been awarded more than £58,000 by Alzheimer's Research UK to study chemical signals in the brain in Alzheimer's disease. The research will study the chemical signals that control learning and memory in an attempt to understand more about Alzheimer's and search for new treatments.
Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."
The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.
Between 17-21 October 2009, the 39th annual conference of the Society of Neuroscience drew some 30,500 people to the great city of Chicago, which was more balmy than windy for the occasion. Your Alzforum reporters have been busy roaming the halls, buttonholing scientists for their comments on the presentations, and putting together reports on the most significant advances.
› Verified 4 days ago
Jeffrey R Michell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4177 | |
Stephen Joseph Craane, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15290 Pennock Ln, Apple Valley, MN 55124 Phone: 952-853-8800 Fax: 952-431-6966 | |
Todd Joseph Stolpman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14655 Galaxie Ave, Apple Valley, MN 55124 Phone: 952-432-6161 Fax: 952-432-7019 | |
Holly A Hett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14655 Galaxie Ave, Apple Valley, MN 55124 Phone: 952-432-6161 Fax: 952-432-7019 | |
April Coming Hay, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4100 | |
Christopher Balgobin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4100 |